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The FOXO family of forkhead transcription factors have a pivotal role in determining cell fate in response
to oxidative stress. FOXO activity can either promote cell survival or induce cell death. Increased FOXO-
mediated cell death has been implicated in the pathogenesis of degenerative diseases affecting
musculoskeletal tissues. The aim of this study was to determine the conditions under which one member
of the FOXO family, FOXO3a, promotes cell survival as opposed to cell death. Treatment of primary
human tenocytes with 1 pM hydrogen peroxide for 18 h resulted in increased protein levels of FOXO3a. In
peroxide-treated cells cultured in low serum media, FOXO3a inhibited cell proliferation and protected
against apoptosis. However in peroxide treated cells cultured in high serum media, cell proliferation was
unchanged but level of apoptosis signiﬁcantly increased. Similarly, in tenocytes transduced to over-
express FOXO3a, cell proliferation was inhibited and level of apoptosis unchanged in cells cultured in
low serum. However there was a robust increase in cell death in FOXO3a-expressing cells cultured in
high serum. Inhibition of cell proliferation in either peroxide-treated or FOXO3a-expressing cells cultured
in high serum protected against apoptosis induction. Conversely, addition of a Chk2 inhibitor to
peroxide-treated or FOXO3a-expressing cells overrode the inhibitory effect of FOXO3a on cell prolifer-
ation and led to increased apoptosis in cells cultured in low serum. This study demonstrates that
proliferating cells may be particularly susceptible to the apoptosis-inducing actions of FOXO3a. Inhibition
of cell proliferation by FOXO3a may be a critical event in allowing the pro-survival rather than the pro-
apoptotic activity of FOXO3a to prevail.
© 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
Cells are routinely exposed to oxidative stress as a consequence
of aerobic metabolism, detoxiﬁcation processes as well as through
the generation of reactive oxygen species (ROS) during signalling
pathway activation. Although oxidative stress is essential for
maintenance of normal cell function, it can also be pathological
leading to tissue degeneration.
Musculoskeletal tissues such as muscle and tendon are highly
susceptible to oxidative damage-associated degenerative disease.
In such diseases, increased expression of a family of transcription
factors known as the FOXO forkheads has shown to have a major
causal role in disease pathology. FOXOs are induced by oxidativef Health, Massey University,
land. Fax: þ64 6 3505657.
Poulsen).
r Inc. This is an open access articlstress and directly regulate transcription of genes encoding anti-
oxidants, cell cycle regulators as well as pro-apoptotic proteins.
FOXO activation can result in promotion of cell survival or cell death
[1]. Which of the two occurs seems to depend on the cell envi-
ronment [2e6]. Understanding why FOXO activation results in
initiation of cell death rather than facilitation of cell survival under
disease conditions is essential for understanding the pathogenesis
of tissue degeneration.
In humans there are four FOXO family members, of which
FOXO1 and FOXO3a have been most frequently implicated in
oxidative stress-associated degenerative disease. In vitro studies
have yielded varying results in terms of 1) which FOXO is upregu-
lated in response to oxidative stress and 2) the outcome of FOXO
activity on cell survival. The purpose of the present study is to
establish the conditions under which FOXO3a is upregulated
in vitro and to determine how the cell environment inﬂuences the
pro-survival versus the pro-apoptotic activity of FOXO3a.e under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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2.1. Cell culture
Tendon tissue was obtained from the Oxford Musculoskeletal
BioBank and was collected with informed donor consent in full
compliance with National and Institutional ethical requirements,
the United Kingdom Human Tissue Act, and the Declaration of
Helsinki. Human tenocytes were isolated by explant culture of
hamstring tendon surplus to requirements for allograft repair of
ruptured anterior cruciate ligament as previously described [7].
Unless otherwise stated, tenocytes were cultured in DMEM/F12
with 5% FBS without antibiotics. Cells were passaged at 70%
conﬂuence and used up until passage 3. For experiments, cells were
plated at a concentration of 50,000 cells/ml (approximately 60%
conﬂuence). Cells were allowed to adhere overnight; experimental
treatments commenced on the following day.
MCF7 cells were obtained from Dr Claire Edwards, University of
Oxford. MCF7s were cultured in DMEM with 10% FBS without an-
tibiotics. Cells were passaged at 70e80% conﬂuence and used be-
tween passages 21 and 23.
2.2. RNAi-mediated gene silencing
Cells were cultured for 18 h in serum-free DMEM-F12 with
lipofectamine RNAimax (Life Technologies, Paisley UK) (1.64 ml/ml)
and 36 pM siRNA (either non-targeting control catalogue number
D-001810-01-05, ThermoScientiﬁc, Rockford, IL, USA or
FOXO3a (catalogue no. 4392420 s5260, Life Technologies, Paisley,
UK.). Lipofectamine-containing media was subsequently removed
and replaced with standard growth media (DMEM-F12 containing
5% FBS) for a further 24 h before treating as appropriate for indi-
vidual experiments. Success of gene knockdown was conﬁrmed by
Western Blotting 48 h post-transfection.
2.3. Adenoviral-mediated gene transduction
Cells were infected with either adFOXO3a, adFOXO3AAA (both
Vector Biolabs, Philadelphia, USA; catalogue no. 1576 and 1025
respectively) or adGFP (a kind gift from Prof Jillian Cornish, Uni-
versity of Auckland, NZ) at MOI35 using Xtremegene HP (Roche
Diagnostics Ltd, Burgess Hill, UK) following the manufacturer's
instructions. Transduction efﬁciency was approximately 90%. Suc-
cess of gene transduction was conﬁrmed by western blotting 24 h
post-infection.
2.4. Western blotting
Cells were sonicated in standard lysis buffer containing protease
and phosphatase inhibitors. Proteins were quantiﬁed using the
Pierce 660 protein determination assay (ThermoScientiﬁc, Rockford
IL, USA) and lysates diluted as appropriate to ensure equal loading
of total protein. Western blots were carried out according to stan-
dard protocols [7] and proteins visualized using Pierce WestDura
detection reagents (ThermoScientiﬁc, Rockford, IL, USA) using a
Chemi Doc-It imaging system with Biochemi HR camera (UVP,
Upland, CA, USA). The following primary antibody was used:
FOXO3a clone 75D8 (Cell Signaling Technologies, Danvers, MA,
USA).
2.5. Apoptosis and cell death detection
Apoptosis was detected by measuring enzyme activity of cas-
pase 3/7 using the Apo-One® Homogeneous Caspase 3/7 Assay
following the manufacturer's instructions (Promega Corporation,Madison, USA). Cell death was conﬁrmed using a Live/Dead
Viability/Cytotoxicity staining kit following the manufacturer's in-
structions (Life Technologies, Paisley, UK). A Nikon Eclipse Te300
microscope equipped with a QImaging Retiga 2000R Fast 1394
camera (Nikon Corporation, Tokyo, Japan)) was used to image
stained cells.2.6. Cell proliferation
Cell proliferation was measured using the Click-it® EdU Alexa-
Fluor®-555 Imaging Kit following the manufacturer's instructions
(Life Technologies, Paisley, UK). Brieﬂy, cells were incubated with
the modiﬁed thymidine analogue EdU for 18 h. EdU (which is
incorporated into cells undergoing DNA replication) was then ﬂu-
orescently labelled with AlexaFluor-555. Cells were then stained
with Hoechst 33344 in order to allow determination of total cell
number. Images were captured using a Nikon Eclipse Te300 mi-
croscope equippedwith a QImaging Retiga 2000R Fast 1394 camera
(Nikon Corporation, Tokyo, Japan). Edu-positive cells as a percent-
age of total cells was calculated based on manual counts of Alexa-
Fluor 555 and Hoechst 33344-labelled cells.2.7. Statistical analysis
All experiments were repeated at least three times using
different tissue donors for each experimental replicate. Results
were analysed by one-way ANOVAwith post hoc Tukey testing or by
t-test if only two conditions were tested. Data were analysed using
Prism 5.0b (GraphPad Software, La Jolla, California, USA). P value
0.05 was considered statistically signiﬁcant. Results are expressed
as mean ± SD.3. Results
3.1. FOXO3a but not FOXO1 is induced by low level oxidative stress
and protects against apoptosis induction in primary human
tenocytes
Under physiological conditions, extracellular peroxide concen-
trations can vary from picomolar to micromolar levels depending
on the source of peroxide generation [8,9]. We previously found
that treatment of tenocytes with micromolar concentrations of
peroxide resulted in increased protein levels of FOXO1 but not
FOXO3a. Therefore, we wanted to determine if treatment with
picomolar concentrations also resulted in upregulation of FOXOs.
We found protein levels of FOXO3a but not FOXO1 were higher in
tenocytes treated with 1 pM hydrogen peroxide for 18 h compared
to untreated controls (Fig. 1A).
Level of cell proliferation was signiﬁcantly lower (Fig. 1B) but
level of apoptosis unchanged (Fig. 1C) in cells treated with 1 pM
hydrogen peroxide for 24 h compared to untreated controls. In
order to determine the effects of FOXO3a in peroxide-treated cells,
we knocked down FOXO3a expression using RNAi (siFOXO3a)
(Fig. 1D). We found there was no signiﬁcant difference in cell pro-
liferation in peroxide-treated siFOXO3a cells compared to control
cells transfected with a non-targeting siRNA (siCntrl) indicating
FOXO3a activity was responsible for the inhibition of cell prolifer-
ation following peroxide treatment (Fig. 1E). Interestingly, we
found level of apoptosis was signiﬁcantly higher in peroxide treated
cells in which FOXO3a had been knocked down compared to
peroxide-treated controls suggesting that FOXO3a had pro-survival
effects (Fig. 1F).
Fig. 1. FOXO3a protects against apoptosis in oxidative stress-exposed cells. A. Treatment of primary human tendon-derived ﬁbroblasts (tenocytes) with 1 pM hydrogen peroxide for
8 h resulted in increased protein levels of FOXO3a but not FOXO1 as determined by western blot. B. The percentage of proliferating cells (cells staining positive for 5-ethynyl-2-
deoxyuridine (EdU)) was signiﬁcantly lower in cells treated with hydrogen peroxide for 24 h compared to untreated controls. C. No difference in level of apoptosis (measured
using a caspase 3/7 activity assay) was apparent after 24 h of treatment with 1 pM hydrogen peroxide compared to untreated controls. D. Western blot showing the level of
knockdown of FOXO3a protein achieved using RNAi in tenocytes. E. Level of cell proliferation (as determined by EdU-incorporation) was signiﬁcantly higher in peroxide-treated
cells transfected with siFOXO3a compared to in siCntrl cells. F. Caspase 3/7 activity was signiﬁcantly higher in peroxide-treated cells in which FOXO3a expression had been
knocked down by RNAi (siFOXO3a) compared to in peroxide-treated cells transfected with a non-targeting control siRNA sequence (siCntrl). Experiments were conducted on cells
obtained from three different donors. Western blots are representative of those obtained for all 3 patient donors. Results shown are mean ± S.D. for the three experimental
replicates. Differences between treatments marked with * were statistically signiﬁcant (p < 0.05).
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levels
FOXO3a has previously been shown to induce apoptosis in a va-
riety of different cell types including theMCF7breast cancer cell line
[10]. We wanted to determine why upregulation of FOXO3a in low
dose peroxide-treated tenocytes did not result in apoptosis induc-
tion. To this end, we over-expressed FOXO3a in tenocytes using an
adenoviral vector (adFOXO3a) (Fig. 2A). We found there was no
difference in level of apoptosis in adFOXO3a-infected tenocytescompared to controls infected with a GFP-bearing adenoviral
construct (adGFP) (Fig. 2B). To check the validity of our adFOXO3a
construct, we infected MCF7 cells with our adFOXO3a vector.
Consistentwith the ﬁndings in previous studies [10], we found level
of apoptosis was signiﬁcantly higher in adFOXO3a-infected MCF7s
compared to adGFP-infected controls (Fig. 2C).
MCF7 cells are typically cultured in media containing a higher
percentage serum (10% FBS) than that routinely used to culture
tenocytes (5% FBS). We wanted to determine if the difference in
outcome of FOXO3a activation in tenocytes compared to MCF7 cells
Fig. 2. The apoptosis-inducing ability of FOXO3a is dependent on serum level. A. Western blot showing the increase in protein level of FOXO3a obtained following infection of
tenocytes with an adenoviral vector bearing a FOXO3a expression construct (adFOXO3a). Control cells were infected with a GFP-bearing adenoviral vector (adGFP). B. There was no
difference in level of caspase 3/7 activity between cells infected with adFOXO3a and adGFP-infected controls 18 h post-infection. C. Caspase 3/7 activity was signiﬁcantly higher in
MCF7 cells infected with adFOXO3a compared to adGFP. D. Caspase 3/7 activity was signiﬁcantly higher in primary human tenocytes cultured in media supplemented with 10% FBS
compared to either adGFP-infected control cells cultured in 10% FBS or adFOXO3a-infected cells cultured in 5% FBS. Measurements were made 18 h post-infection. E. Photomi-
crographs (100) of adGFP- or adFOXO3a-infected tenocytes cultured in 5% or 10% FBS for 24 h followed by staining with calcein AM (green, live cells) and ethidium homodimer
(red, dead cells). F. The average number of live (calcein-AM positive) cells in cultures following 24 h of treatment with 1 pM peroxide or 24 h post infection with adFOXO3a. G.
Caspase 3/7 activity was signiﬁcantly higher in primary human tenocytes treated with 1 pM hydrogen peroxide and cultured in 10% FBS compared to either untreated controls
cultured in 10% FBS or peroxide-treated cells cultured in 5% FBS. Experiments were conducted on cells obtained from three different donors. Western blot images shown are
representative of those obtained for all 3 patient donors. Results shown are mean ± S.D. for the three experimental replicates. Differences between treatments marked with * were
statistically signiﬁcant (p < 0.05). (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web version of this article.)
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result of the different cell culture conditions. To this end, we
cultured adFOXO3a-infected tenocytes in media containing 10%
serum and assessed level of apoptosis. We found caspase 3/7 ac-
tivity was signiﬁcantly higher in tenocytes infected with adFOXO3a
cultured in 10% FBS compared to adGFP controls (Fig. 2D). By 24 hpost-infection, there was evidence of ethidium homodimer incor-
poration (an indicator of cell death) (Fig. 2E) and a noticeable
reduction in overall cell number (Fig. 2F) in adFOXO3a infected
cultures.
To test if serum levels also inﬂuenced the activity of endogenous
FOXO3a, we treated tenocytes cultured in 10% serum with 1 pM
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treated cells cultured in 10% FBS compared to untreated controls
(Fig. 2G) however apoptosis induction was slower than that
observed in adFOXO3a-infected cells. A statistically signiﬁcant in-
crease in caspase 3/7 activity was only observed following 24 h of
peroxide treatment compared to 18 h post-adFOXO3a infection. The
difference in live cell number between untreated controls and
peroxide-treated cells cultured in 10% FBS was much smaller than
that between adGFP- and adFOXO3a-infected cells cultured under
the same conditions (Fig. 2F).
3.3. The anti-proliferative effects of FOXO3a are dependent on
serum levels
Next wewanted to determine if serum levels also inﬂuenced the
ability of FOXO3a to inhibit cell proliferation. In adFOXO3a-infected
tenocytes cultured in 5% FBS, level of proliferationwas signiﬁcantly
lower than in adGFP-infected cells cultured under the same con-
ditions (Fig. 3A). Although the level of proliferation was still
signiﬁcantly lower in adFOXO3a-infected tenocytes cultured in 10%
FBS compared to adGFP-infected cells the difference was much less
dramatic than in cells cultured in 5% FBS (Fig. 3A). This suggests that
high serum hinders the ability of FOXO3a to inhibit cell prolifera-
tion. In support of this, we found therewas no signiﬁcant difference
in cell proliferation between peroxide-treated cells and untreated
controls cultured in 10% FBS (Fig. 3B) indicating high serum pre-
vented the anti-proliferative effects of endogenous FOXO3a.
3.4. Inhibiting cell proliferation protects against FOXO3a-induced
apoptosis
Since increasing the serum content of the media had opposing
effects on the ability of FOXO3a to inhibit cell proliferation or
induce apoptosis, we wanted to determine if inhibition of cell
proliferation could protect against FOXO3a-induced apoptosis. We
used the CDK4/6 inhibitor PD0332991 (30 nM; Sigma, Poole, UK) to
inhibit cell proliferation in adFOXO3a-infected tenocytes cultured
in 10% FBS (refer Supplementary information for data demon-
strating the effectiveness of the inhibitor). We found level of
apoptosis was signiﬁcantly lower in adFOXO3a-infected cells
treated with the inhibitor compared to non-inhibitor treated cellsFig. 3. The anti-proliferative activity of FOXO3a is dependent on serum level. A. Level of cell
infected cells cultured in either 5% or 10% FBS compared to adGFP-infected controls cult
adFOXO3a-infected cells and adGFP-infected controls was much smaller in cells cultured in
between tenocytes treated with 1 pM hydrogen peroxide and untreated controls when cell
different donors. Results shown are mean ± S.D. for the three experimental replicates. Diff(Fig. 4A). Similarly, level of apoptosis was signiﬁcantly lower in cells
cultured in 10% FBS and treated with peroxide and the CDK4/6
inhibitor compared to in cells treated with peroxide alone (Fig. 4B).
Next we used a Chk2 inhibitor (C3742, Sigma, Poole UK) to prevent
cell cycle arrest in cells grown in 5% FBS (refer Supplementary
information for data demonstrating the effectiveness of the inhib-
itor). We found level of apoptosis was signiﬁcantly higher in
adFOXO3a-infected cells cultured in 5% FBS and treated with the
Chk2 inhibitor (22 nM) compared to non-inhibitor treated cells
(Fig. 4C). Similarly, level of apoptosis was also signiﬁcantly higher in
cells cultured in 5% FBS co-treated with peroxide and the Chk2
inhibitor compared to cells treated with peroxide alone (Fig. 4D).
4. Discussion
It is widely accepted that oxidative stress has a major role in the
pathogenesis of degenerative disease. However oxidative stress is a
necessary consequence of aerobic life. As a result, cells utilise a
variety of strategies to quench ROS and prevent or repair oxidative
damage. The FOXO transcription factors upregulate expression of
genes which are important components of the cellular antioxidant
defence system, allowing cells to survive oxidative stress. However
FOXOs can also induce apoptosis. In musculoskeletal tissues such as
muscle and tendon, upregulation of FOXO-mediated apoptosis is
believed to have a major causal role in the development of
degenerative disease. In the present study, we sought to determine
the conditions which govern whether FOXO3a activity promotes
cell survival or cell death in primary human tenocytes.
We found FOXO3a protein levels were elevated in human
tenocytes following treatment with low dose (1 pM) hydrogen
peroxide for 18 h. Under standard growth conditions (5% FBS),
FOXO3a activity in peroxide-treated cells resulted in inhibition of
cell proliferation and protection against apoptosis. However in
tenocytes cultured in 10% FBS, there was no reduction in cell pro-
liferation with peroxide treatment but a signiﬁcant increase in
caspase 3/7 activity was observed indicating induction of apoptosis.
Live cell number was also signiﬁcantly lower in peroxide-treated
cells cultured in 10% FBS compared to controls. A much more
overt effect on live cell number was observed in tenocytes trans-
duced to over-express FOXO3a. In these cells, exogenous FOXO3a
inhibited cell proliferation when cells were cultured in 5% FBS butproliferation (as measured by EdU incorporation) was signiﬁcantly lower in adFOXO3a-
ured under the same conditions. However the magnitude of the difference between
10% FBS compared to 5% FBS. B. Level of cell proliferation was not signiﬁcantly different
s were cultured in 10% FBS. Experiments were conducted on cells obtained from three
erences between treatments marked with * were statistically signiﬁcant (p < 0.05).
Fig. 4. Inhibition of cell proliferation protects against FOXO3a-mediated apoptosis. A. In cells cultured in 10% FBS, caspase 3/7 activity was signiﬁcantly lower in adFOXO3a-infected
cells treated with a CDK4/6 inhibitor compared to non-inhibitor treated adFOXO3a-infected cells. B. Similarly in cells cultured in 10% FBS, caspase 3/7 activity was signiﬁcantly lower
in cells co-treated with peroxide (1 pM) and a CDK4/6 inhibitor compared to cells treated with peroxide alone. C. In cells cultured in 5% FBS, caspase 3/7 activity was signiﬁcantly
higher in adFOXO3a-infecetd cells treated with a Chk2 inhibitor compared to non-inhibitor-treated adFOXO3a-infected cells. D. Caspase 3/7 activity was signiﬁcantly higher in cells
cultured in 5% FBS and co-treated with peroxide (1 pM) and the Chk2 inhibitor compared to cells cultured under the same conditions and treated with peroxide alone. Experiments
were conducted on cells obtained from three different donors. Results shown are mean ± S.D. for the three experimental replicates. Differences between treatments marked with *
were statistically signiﬁcant (p < 0.05).
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tion in FOXO3a over-expressing cells was more rapid than in
peroxide-treated cells with a signiﬁcant increase in caspase 3/7
activity detectable 18 h post gene transduction compared to after
24 h of peroxide treatment. However the relative increase in cas-
pase activity observed between adFOXO3a-infected cells and
adGFP-infected controls was of a similar magnitude to that
observed between peroxide treated cells and untreated controls.
This may indicate that indicate that caspase activity peaked earlier
than 18 h post-infection or that cell death pathways other than just
apoptosis were involved in inducing cell death in adFOXO3a-
infected cells.
Given the low concentration of hydrogen peroxide used in this
study, the increase in apoptosis in tenocytes cultured in 10% FBS
was somewhat surprising. A number of factors may have contrib-
uted to the sensitivity of tenocytes to low dose peroxide. Although
cells are routinely exposed to oxidative stress in vivo, in healthy
tissues the duration of this exposure is usually very transient. In
this study cells were continually exposed to low dose peroxide for
18e24 h. Such prolonged exposure may have exhausted cellular
defence mechanisms hence resulting in cell death. Secondly,because tenocytes are sparsely distributed throughout healthy
tendon tissue, tenocyte cultures at approximately 60% conﬂuence
were used for these experiments. At this level of conﬂuence, cells
are likely to be particularly responsive to the pro-proliferative ef-
fects induced by higher FBS concentrations since very few cells
would be subject to contact inhibition. This may be a crucial factor
as our results indicate that proliferating cells are particularly sus-
ceptible to the pro-apoptotic activity of FOXO3a. We found that
blocking the anti-proliferative activity of FOXO3a either by
culturing in high serum or by using a chemical inhibitor of the Chk2
cell cycle checkpoint resulted in increased apoptosis. Interestingly
this is similar to the mechanism of action of p53, another stress-
induced transcription factor with both pro-survival and pro-
apoptotic activity. Initiation of cell cycle arrest by p53 is crucial
for enabling p53-mediated repair of stress-induced damage [11].
Like p53, FOXO3a directly regulates transcription of a number of
genes involved in stress defence [12,13]. FOXO3a has also previ-
ously been shown to protect quiescent cells from oxidative stress-
induced damage through the induction of genes involved in
stress defence [12]. It seems likely that by inhibiting cell prolifer-
ation, FOXO3a “buys time”, preventing the replication of potentially
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ponents whilst stress defences (such as antioxidant enzymes) work
to counter the stress. If FOXO3a is unable to inhibit proliferation in
stress-exposed cells, the potential for the propagation of DNA
damage is high. FOXO3a has previously been shown to assist in the
induction of DNA damage-induced apoptosis [14]. It follows
therefore that prevention of the anti-proliferative activity of
FOXO3a increases the susceptibility of cells to damage-induced
apoptosis.
Increased levels of both FOXO1 and FOXO3a are common in
muscle atrophy and have been implicated as having a major role in
disease pathogenesis [15e18]. Increased FOXO levels have also been
observed in various other degenerative conditions affecting con-
nective tissues [19,20]. Understanding the factors which inﬂuence
the ability of FOXO3a to induce cell cycle arrest may have important
consequences for understanding why FOXO3a activation contrib-
utes to, rather than protects against, the development of these
diseases.
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